A recent meta-analysis indicated that SCCA and SCCA-IgM exhibit moderate diagnostic accuracy as novel tumor makers of HCC, although the value of the combination of SCCA/SCCA-IgM and AFP requires further investigation [144]. Here, CD40LG is linked to hepatocellular carcinoma.